Gene: ZNF670
Official Full Name: zinc finger protein 670provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Acts upstream of or within lipid metabolic process. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22176 | ZNF670 Knockout cell line (HeLa) | Human | ZNF670 | 1:3~1:6 | Negative | Online Inquiry |
KO22177 | ZNF670 Knockout cell line (HCT 116) | Human | ZNF670 | 1:2~1:4 | Negative | Online Inquiry |
KO22178 | ZNF670 Knockout cell line (HEK293) | Human | ZNF670 | 1:3~1:6 | Negative | Online Inquiry |
KO22179 | ZNF670 Knockout cell line (A549) | Human | ZNF670 | 1:3~1:4 | Negative | Online Inquiry |
ZNF670 Gene Knockout Cell Lines are specially engineered cellular models characterized by the targeted inactivation of the ZNF670 gene, which encodes a zinc-finger transcription factor implicated in various biological processes, including genomic stability and transcriptional regulation. These cell lines serve as critical tools for understanding the functional roles of the ZNF670 protein in cellular pathways, disease models, and gene regulation mechanisms.
The key function of ZNF670 Gene Knockout Cell Lines lies in their ability to elucidate the biological impact of ZNF670 deficiency. By utilizing CRISPR-Cas9 technology, researchers can knock out the gene, leading to the observation of phenotypic changes and the consequent alteration in gene expression profiles. This innovative approach allows for precise investigations into the gene's role in cellular resistance to stress, differentiation, and apoptosis, thereby providing insights into cancer biology and other pathophysiological conditions.
In research and clinical settings, these knockout cell lines are invaluable for drug discovery, validation of therapeutic targets, and functional genomics studies. Their relevance is underscored by the increasing interest in zinc-finger proteins as potential modifiers of disease pathways, making them ideal candidates for further exploration in both basic and applied sciences.
Compared to traditional methods, such as siRNA knockdown or transgenic models, ZNF670 Gene Knockout Cell Lines offer a more permanent and stable gene alteration, which leads to reproducible results over extensive experimental timelines. Additionally, these cell lines are readily adaptable for high-throughput screening applications, providing significant advantages for researchers aiming to accelerate the pace of discovery.
The value of ZNF670 Gene Knockout Cell Lines extends beyond mere research; they represent a leap forward in our capability to dissect intricate genetic networks. Researchers and clinicians can harness these tools to unlock new avenues in understanding disease mechanisms and driving innovation in therapeutic strategies.
Our company, with a longstanding commitment to advancing biological research, meticulously develops and provides high-quality gene knockout cell lines tailored for the scientific community's needs, ensuring that our customers are equipped with tools that foster groundbreaking discoveries in molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.